Press "Enter" to skip to content

New patent expiration for Palatin Technologies drug VYLEESI (AUTOINJECTOR)

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Palatin Technologies drug VYLEESI (AUTOINJECTOR)

Annual Drug Patent Expirations for VYLEESI+%28AUTOINJECTOR%29
Annual Drug Patent Expirations for VYLEESI+%28AUTOINJECTOR%29

Vyleesi (autoinjector) is a drug marketed by Palatin Technologies and is included in one NDA. It is available from one supplier. There are five patents protecting this drug.

This drug has seventy-three patent family members in twenty-four countries.

The generic ingredient in VYLEESI (AUTOINJECTOR) is bremelanotide acetate. One supplier is listed for this compound. Additional details are available on the bremelanotide acetate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Palatin Technologies drug VYLEESI (AUTOINJECTOR)
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions